Growth hormone promotes lipolysis and lean tissue preservation
Lower tirzepatide doses (510mg weekly) reduce GI side effect burden while still providing meaningful appetite suppression, allowing researchers to maintain protocol adherence without the nausea and vomiting that causes 1015% of subjects to discontinue at higher doses
No FDA status Not FDA-approved as a drug These compounds are not interchangeable
Ensures that every dose is free of harmful bacterial byproducts and complies with USP 85 safety standards
When taken in the form of nicotinic acid, niacin can lead to high blood pressure, abdominal pain, impaired vision, and liver damage when consumed in high doses of 13 grams per day (16)
It is not approved by the FDA for fat loss or any other use, and any clinical application falls under the supervision of a licensed medical provider